IYLD logoIYLD
iShares Morningstar Multi-Asset Income ETF

0
Loading...
Loading...
News
all
press releases
News Placeholder
This Pharma Stock Is Down 19% In 2025 But Just Received An ‘Explosive News’ – Find Out More
The company’s U.S. affiliate announced that the U.S. Food and Drug Administration has approved a generic version of Liraglutide injection, known as Saxenda.
Stocktwits·9d ago

Latest IYLD News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.